Status:
UNKNOWN
Apelin12 in Acne Vulgaris
Lead Sponsor:
Assiut University
Conditions:
Acne Vulgaris
Eligibility:
All Genders
Brief Summary
Acne vulgaris is a common chronic inflammatory disease of the pilosebaceous unit which is characterized by the formation of non-inflammatory open and closed comedones and inflammatory papules, pustule...
Detailed Description
Acne lesions may vary in number during the natural course of the disease and multiple measurements have been developed which is based on clinical examination and photographic documentation, to measure...
Eligibility Criteria
Inclusion
- Acne vulgaris patients from different ages and sex.
Exclusion
- Pregnant and lactating females.
- Local cutaneous infection or any other dermatological diseases.
- Diabetic patients or severe systemic disease such as liver and renal failure.
Key Trial Info
Start Date :
May 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03480503
Start Date
May 1 2018
End Date
December 1 2019
Last Update
March 29 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.